Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CDC42EP2 |
| Upstream (Parents) |
|---|
| (<<) AVP → CDC42EP2 |
| (<<) BCAR1 → CDC42EP2 |
| (<<) CASP9 → CDC42EP2 |
| (<<) CCL24 → CDC42EP2 |
| (<<) CCNL1 → CDC42EP2 |
| (<<) CEP170 → CDC42EP2 |
| (<<) CREB3L4 → CDC42EP2 |
| (<<) EHD1 → CDC42EP2 |
| (<<) GLS → CDC42EP2 |
| (<<) ILKAP → CDC42EP2 |
| (<<) ITGB8 → CDC42EP2 |
| (<<) LRP3 → CDC42EP2 |
| (<<) MAP3K11 → CDC42EP2 |
| (<<) PRKAA1 → CDC42EP2 |
| (<<) PTEN → CDC42EP2 |
| (<<) RARA → CDC42EP2 |
| (<<) RNASE7 → CDC42EP2 |
| (<<) SH3GL1 → CDC42EP2 |
| (<<) SLC20A1 → CDC42EP2 |
| (<<) VPS37B → CDC42EP2 |
| (<<) ZNF205 → CDC42EP2 |
| Downstream (Children) |
|---|
| CDC42EP2 → AREG (>>) |
| CDC42EP2 → BAD (>>) |
| CDC42EP2 → BBS1 (>>) |
| CDC42EP2 → BCL3 (>>) |
| CDC42EP2 → CREB3 (>>) |
| CDC42EP2 → CSNK1D (>>) |
| CDC42EP2 → DRD4 (>>) |
| CDC42EP2 → EIF2AK2 (>>) |
| CDC42EP2 → ELFN1 (>>) |
| CDC42EP2 → FLJ22184 (>>) |
| CDC42EP2 → GNG5 (>>) |
| CDC42EP2 → KREMEN1 (>>) |
| CDC42EP2 → MLXIPL (>>) |
| CDC42EP2 → NGEF (>>) |
| CDC42EP2 → PLCB3 (>>) |
| CDC42EP2 → PPP2R5B (>>) |
| CDC42EP2 → RARB (>>) |
| CDC42EP2 → RPA4 (>>) |
| CDC42EP2 → RPS6KA3 (>>) |
| CDC42EP2 → SHC2 (>>) |
| CDC42EP2 → SLC5A1 (>>) |
| CDC42EP2 → SLMO2 (>>) |
| CDC42EP2 → SOX18 (>>) |
| CDC42EP2 → SOX2 (>>) |
| CDC42EP2 → SUMF1 (>>) |
| CDC42EP2 → THRA (>>) |
| CDC42EP2 → ZNF467 (>>) |
